Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Schrödinger Wins Investment From Gates

by Michael McCoy
May 10, 2010 | A version of this story appeared in Volume 88, Issue 19

Microsoft cofounder Bill Gates has invested in the computational chemistry company Schrödinger through Cascade Investment, his investment arm. Schrödinger isn’t disclosing the size of the investment, but Gates told the Wall Street Journal that it is $10 million. Schrödinger has about 140 employees, more than half of whom are Ph.D. chemists. Its traditional business is selling chemical simulation software to drug companies. More recently, it has entered drug discovery collaborations that include milestone payments.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.